New pill could ease stiffness and pain for ankylosing spondylitis patients
NCT ID NCT05861102
First seen Jan 11, 2026 · Last updated May 18, 2026 · Updated 15 times
Summary
This study tests a new drug called jaktinib in 265 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants receive either jaktinib or a placebo to see if the drug improves symptoms like pain and movement. The main goal is to measure a 40% improvement in key areas after 16 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
RenJi Hospital
Shanghai, Shanghai Municipality, 200001, China
Conditions
Explore the condition pages connected to this study.